Nuclear Medicine: Page 16

QIBA announces inaugural fellowship recipients

By AuntMinnie.com staff writers

The RSNA's Quantitative Imaging Biomarkers Alliance (QIBA) and its partner, the Academy for Radiology & Biomedical Imaging Research, have announced recipients of the first Academy Council of Early Career Investigators in Imaging fellowship.

October 30, 2022

ViewRay touts results of MIRAGE trial

By AuntMinnie.com staff writers

ViewRay highlighted results from its phase III Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy for Prostate Cancer (MIRAGE) trial at the recent American Society for Radiation Oncology annual meeting in San Antonio.

October 26, 2022

ITM-11 gets fast-track nod from FDA

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich SE's ITM-11 was recently granted fast-track designation by the U.S. Food and Drug Administration (FDA).

October 26, 2022

DOE breaks ground on new isotope research facility

By AuntMinnie.com staff writers

The U.S. Department of Energy (DOE) broke ground October 24 on a new isotope research facility at Oak Ridge National Laboratory (ORNL) in Tennessee.

October 25, 2022

Spectrum highlights new SPECT/CT capability

By AuntMinnie.com staff writers

Spectrum Dynamics is highlighting a new nuclear medicine imaging capability: to image high-energy isotopes using solid-state detector technology in a 360˚ cadmium zinc telluride-based, wide-bore SPECT/CT configuration.

October 19, 2022

Shine secures Dutch approval for terbium isotope development grant

By AuntMinnie.com staff writers

Shine Technologies has secured approval from the Dutch government for a grant proposal to develop terbium isotopes for nuclear medicine imaging.

October 17, 2022

ITM to boost Lu-177 production

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich completed work on a new production line for non-carrier-added lutetium-177 (Lu-177) at its manufacturing facility in Garching, Germany.

October 12, 2022

Nucleus RadioPharma forms to provide radiopharmaceuticals

By AuntMinnie.com staff writers

Venture capital firm Eclipse and the Mayo Clinic are creating and providing seed funding for a new company called Nucleus RadioPharma that aims to provide cancer patients access to therapeutic radiopharmaceuticals.

October 11, 2022

SPECT/CT AI model predicts major adverse cardiac events

By Will Morton

A deep-learning model developed for SPECT myocardial perfusion imaging could help clinicians identify patients at risk for major adverse cardiac events.

October 11, 2022

NorthStar signs deal with Eckert & Ziegler for hot cells

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has signed an agreement with Eckert & Ziegler Isotope Technologies Dresden for hot cells and related equipment to be used in NorthStar's construction of a production facility for noncarrier-added actinium-225 (Ac-225).

October 10, 2022

Telix highlights EANM presentations

By AuntMinnie.com staff writers

Telix Pharmaceuticals is highlighting presentations on the company's theranostics radiopharmaceuticals that will take place at the European Association of Nuclear Medicine (EANM) 2022 Congress, in Barcelona, Spain, October 15-19.

October 10, 2022

Clarity highlights first dosage of patient in prostate cancer trial

By AuntMinnie.com staff writers

Radiopharmaceutical developer Clarity Pharmaceuticals is highlighting the dosing of the first patient in the therapeutic phase of a clinical trial examining the effectiveness of the company's theranostic products.

October 6, 2022

Previous Page

Page 16 of 438

Next Page